FrieslandCampina expands its lactoferrin production capacity

September 16, 2020

FrieslandCampina Ingredients is expanding its lactoferrin production capacity in its Veghel facility by 60 metric tons in 2022 to expand its early life nutrition and adult nutrition segments.

Ingredients (Netherlands) is expanding its lactoferrin production capacity in its Veghel facility by 60 metric tons in 2022 to expand its early life nutrition and adult nutrition segments. This expansion will bring its total capacity to 70 mt per annum. 

“Lactoferrin is a key ingredient in early life nutrition and has also shown potential health benefits for adults related to the immune system,” said Herman Ermens, president a.i. at FrieslandCampina Ingredients, in a press release. “Global demand for lactoferrin almost doubled between 2014 and 2019. By significantly expanding our production capacity, we can meet the needs of our customers. In addition, this investment exemplifies our strategy of growth through valued-added ingredients. Thanks to our technological leadership and unique experience, we’re perfectly placed to offer lactoferrin of the highest quality that complies with the strictest global regulatory requirements.”

Anne Peter Lindeboom, managing director early life nutrition at FrieslandCampina Ingredients, added: “FrieslandCampina was one of the first companies to start producing lactoferrin over 25 years ago. Today’s announcement shows we’re committed to identifying and investing in the ingredients that bring the best possible value for our customers.”

The company’s lactoferrin is 96% pure and directly extracted from raw milk. The product is spray dried and is recognized for its high consistency and excellent dry blending properties. To maintain these high standards, the expanded production location will feature state-of-the-art technology. In addition, the plant will use 100% green electricity.